These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10477433)

  • 1. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.
    Guilford PJ; Hopkins JB; Grady WM; Markowitz SD; Willis J; Lynch H; Rajput A; Wiesner GL; Lindor NM; Burgart LJ; Toro TT; Lee D; Limacher JM; Shaw DW; Findlay MP; Reeve AE
    Hum Mutat; 1999; 14(3):249-55. PubMed ID: 10477433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin germline mutations in familial gastric cancer.
    Guilford P; Hopkins J; Harraway J; McLeod M; McLeod N; Harawira P; Taite H; Scoular R; Miller A; Reeve AE
    Nature; 1998 Mar; 392(6674):402-5. PubMed ID: 9537325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
    Keller G; Vogelsang H; Becker I; Hutter J; Ott K; Candidus S; Grundei T; Becker KF; Mueller J; Siewert JR; Höfler H
    Am J Pathol; 1999 Aug; 155(2):337-42. PubMed ID: 10433926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline E-cadherin mutations in familial lobular breast cancer.
    Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
    J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
    Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
    Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer.
    Stone J; Bevan S; Cunningham D; Hill A; Rahman N; Peto J; Marossy A; Houlston RS
    Br J Cancer; 1999 Apr; 79(11-12):1935-7. PubMed ID: 10206317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
    Xie ZM; Li LS; Laquet C; Penault-Llorca F; Uhrhammer N; Xie XM; Bignon YJ
    Cancer; 2011 Jul; 117(14):3112-7. PubMed ID: 21271559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A germline E-cadherin mutation in a family with gastric and colon cancer.
    Salahshor S; Hou H; Diep CB; Loukola A; Zhang H; Liu T; Chen J; Iselius L; Rubio C; Lothe RA; Aaltonen L; Sun XF; Lindmark G; Lindblom A
    Int J Mol Med; 2001 Oct; 8(4):439-43. PubMed ID: 11562785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds].
    Jiang Y; Wan YL; Wang ZJ; Zhao B; Zhu J; Huang YT
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):914-7. PubMed ID: 15363252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.